Bolstering Innovative Options to Save Immediately on Medicines Act or the BIOSIM Act
This bill increases Medicare payments for biosimilars for five years. The bill applies to biosimilars for which the average sales price or wholesale acquisition cost is less than that of the reference biological product, as specified.
| Action Date | Type | Text | Source |
|---|---|---|---|
| 2021-04-23 | Committee | Referred to the Subcommittee on Health. | House committee actions |
| 2021-04-22 | Committee | Referred to the Subcommittee on Social Security. | House committee actions |
| 2021-04-22 | Committee | Referred to the Subcommittee on Health. | House committee actions |
| 2021-04-22 | IntroReferral | Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. | House floor actions |
| 2021-04-22 | IntroReferral | Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. | House floor actions |
| 2021-04-22 | IntroReferral | Introduced in House | Library of Congress |